168 related articles for article (PubMed ID: 29341562)
1. Synchronous mantle cell lymphoma and prostate adenocarcinoma-is it just a coincidence?
Petković I; Stojnev S; Krstić M; Pejčić I; Vrbić S
Vojnosanit Pregl; 2016 Nov; 73(11):1072-5. PubMed ID: 29341562
[TBL] [Abstract][Full Text] [Related]
2. Detection of t(12;14)(p13;q32) in a patient with IGH-CCND1 negative mantle cell lymphoma resembling ultra-high risk chronic lymphocytic leukemia.
Miao Y; Wang R; Fan L; Qiu H; Wu Y; Chen Y; Xu W; Li J
Int J Clin Exp Pathol; 2015; 8(6):7494-8. PubMed ID: 26261659
[TBL] [Abstract][Full Text] [Related]
3. Synchronous primary gastric mantle cell lymphoma and early gastric carcinoma: a case report.
Chong Y; Shin JJ; Cho MY; Cui Y; Kim HY; Park KH
Pathol Res Pract; 2008; 204(6):407-11. PubMed ID: 18282664
[TBL] [Abstract][Full Text] [Related]
4. [Coincidence of adenocarcinoma and MALT lymphoma of the prostate--first report].
Uthoff D; Schmidt S; Matthies C; Tiemann M; Wagner W
Aktuelle Urol; 2009 Mar; 40(2):113-5. PubMed ID: 19177323
[TBL] [Abstract][Full Text] [Related]
5. Male breast cancer and mantle cell lymphoma in a single patient: A case report and literature review.
Liu J; Wei H; Zhu K; Lai L; Han X; Yang Y
Medicine (Baltimore); 2017 Dec; 96(48):e8911. PubMed ID: 29310379
[TBL] [Abstract][Full Text] [Related]
6. Combined cyclophosphamide, vincristine, doxorubicin, and prednisone (CHOP) improves response rates but not survival and has lower hematologic toxicity compared with combined mitoxantrone, chlorambucil, and prednisone (MCP) in follicular and mantle cell lymphomas: results of a prospective randomized trial of the German Low-Grade Lymphoma Study Group.
Nickenig C; Dreyling M; Hoster E; Pfreundschuh M; Trumper L; Reiser M; Wandt H; Lengfelder E; Unterhalt M; Hiddemann W;
Cancer; 2006 Sep; 107(5):1014-22. PubMed ID: 16878325
[TBL] [Abstract][Full Text] [Related]
7. [Malignant lymphoma of the prostate--diagnosis on the second biopsy].
Vetsch G; Baumann CK; Kläy M; Leupin N; Rentsch C; Mueller-Garamvölgyi E; Bürgi U; Schiemann U
Med Klin (Munich); 2008 Apr; 103(4):245-8. PubMed ID: 18484209
[TBL] [Abstract][Full Text] [Related]
8. Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG).
Lenz G; Dreyling M; Hoster E; Wörmann B; Dührsen U; Metzner B; Eimermacher H; Neubauer A; Wandt H; Steinhauer H; Martin S; Heidemann E; Aldaoud A; Parwaresch R; Hasford J; Unterhalt M; Hiddemann W
J Clin Oncol; 2005 Mar; 23(9):1984-92. PubMed ID: 15668467
[TBL] [Abstract][Full Text] [Related]
9. [Prostate cancer histoseminar: Update of the 2016 WHO classification - case n
Compérat E
Ann Pathol; 2017 Jun; 37(3):228-231. PubMed ID: 28554777
[No Abstract] [Full Text] [Related]
10. A rare tumoral combination, synchronous lung adenocarcinoma and mantle cell lymphoma of the pleura.
Hatzibougias D; Bobos M; Karayannopoulou G; Karkavelas G; Karapanagiotidis GT; Foroulis CN; Kostopoulos I
World J Surg Oncol; 2008 Dec; 6():137. PubMed ID: 19114021
[TBL] [Abstract][Full Text] [Related]
11. Non-multiple lymphomatous polyposis form of mantle cell lymphoma in the gastrointestinal tract.
Tamura S; Ohkawauchi K; Yokoyama Y; Higashidani Y; Daibata M; Hiroi M; Yamamori S; Onishi S
J Gastroenterol; 2004 Oct; 39(10):995-1000. PubMed ID: 15549454
[TBL] [Abstract][Full Text] [Related]
12. Mantle cell lymphoma diagnosed from radical prostatectomy for prostate adenocarcinoma: a case report.
Tvrdíková E; Křen L; Kubolková AS; Pacík D
Cesk Patol; 2019; 55(4):231-234. PubMed ID: 31842554
[TBL] [Abstract][Full Text] [Related]
13. Mantle cell lymphoma in a tubular adenoma: unusual presentation with synchronous colonic carcinoma.
Sztarkier I; Levy I; Walfisch S; Delgado J; Benharroch D
Ann Diagn Pathol; 2009 Feb; 13(1):47-9. PubMed ID: 19118782
[TBL] [Abstract][Full Text] [Related]
14. Addition of bortezomib to standard dose chop chemotherapy improves response and survival in relapsed mantle cell lymphoma.
Furtado M; Johnson R; Kruger A; Turner D; Rule S
Br J Haematol; 2015 Jan; 168(1):55-62. PubMed ID: 25146720
[TBL] [Abstract][Full Text] [Related]
15. Mantle cell lymphoma: 2013 Update on diagnosis, risk-stratification, and clinical management.
Vose JM
Am J Hematol; 2013 Dec; 88(12):1082-8. PubMed ID: 24273091
[TBL] [Abstract][Full Text] [Related]
16. Mantle cell lymphoma: 2012 update on diagnosis, risk-stratification, and clinical management.
Vose JM
Am J Hematol; 2012 Jun; 87(6):604-9. PubMed ID: 22615102
[TBL] [Abstract][Full Text] [Related]
17. Reproducibility of SOX-11 detection in decalcified bone marrow tissue in mantle cell lymphoma patients.
Righi S; Pileri S; Agostinelli C; Bacci F; Spagnolo S; Sabattini E
Hum Pathol; 2017 Jan; 59():94-101. PubMed ID: 27720733
[TBL] [Abstract][Full Text] [Related]
18. Confirmation of the mantle-cell lymphoma International Prognostic Index in randomized trials of the European Mantle-Cell Lymphoma Network.
Hoster E; Klapper W; Hermine O; Kluin-Nelemans HC; Walewski J; van Hoof A; Trneny M; Geisler CH; Di Raimondo F; Szymczyk M; Stilgenbauer S; Thieblemont C; Hallek M; Forstpointner R; Pott C; Ribrag V; Doorduijn J; Hiddemann W; Dreyling MH; Unterhalt M
J Clin Oncol; 2014 May; 32(13):1338-46. PubMed ID: 24687837
[TBL] [Abstract][Full Text] [Related]
19. Phase II trial of R-CHOP plus bortezomib induction therapy followed by bortezomib maintenance for newly diagnosed mantle cell lymphoma: SWOG S0601.
Till BG; Li H; Bernstein SH; Fisher RI; Burack WR; Rimsza LM; Floyd JD; DaSilva MA; Moore DF; Pozdnyakova O; Smith SM; LeBlanc M; Friedberg JW
Br J Haematol; 2016 Jan; 172(2):208-18. PubMed ID: 26492567
[TBL] [Abstract][Full Text] [Related]
20. Synchronous adenocarcinoma and mantle cell lymphoma of the stomach.
Kim YI; Koo MY
Yonsei Med J; 2007 Dec; 48(6):1061-5. PubMed ID: 18159604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
